235 related articles for article (PubMed ID: 26404496)
1. T-cell receptor profiling in cancer.
Kirsch I; Vignali M; Robins H
Mol Oncol; 2015 Dec; 9(10):2063-70. PubMed ID: 26404496
[TBL] [Abstract][Full Text] [Related]
2. Immune monitoring technology primer: immunosequencing.
Kirsch I
J Immunother Cancer; 2015; 3():29. PubMed ID: 26113978
[TBL] [Abstract][Full Text] [Related]
3. Immunosequencing applications in cutaneous T-cell lymphoma.
Mandel J; Gleason L; Joffe D; Bhatti S; Nikbakht N
Front Immunol; 2023; 14():1300061. PubMed ID: 38213330
[TBL] [Abstract][Full Text] [Related]
4. Detection of clonal immunoglobulin and T-cell receptor gene recombination in hematological malignancies: monitoring minimal residual disease.
García-Castillo H; Barros-Núñez P
Cardiovasc Hematol Disord Drug Targets; 2009 Jun; 9(2):124-35. PubMed ID: 19519371
[TBL] [Abstract][Full Text] [Related]
5. High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies.
Ye B; Smerin D; Gao Q; Kang C; Xiong X
Cancer Lett; 2018 Mar; 416():42-56. PubMed ID: 29247824
[TBL] [Abstract][Full Text] [Related]
6. Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.
Chun B; Pucilowska J; Chang S; Kim I; Nikitin B; Koguchi Y; Redmond WL; Bernard B; Rajamanickam V; Polaske N; Fields PA; Conrad V; Schmidt M; Urba WJ; Conlin AK; McArthur HL; Page DB
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086949
[TBL] [Abstract][Full Text] [Related]
7. Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis.
Aoki H; Shichino S; Matsushima K; Ueha S
Front Immunol; 2022; 13():807696. PubMed ID: 35154125
[TBL] [Abstract][Full Text] [Related]
8. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.
Brüggemann M; White H; Gaulard P; Garcia-Sanz R; Gameiro P; Oeschger S; Jasani B; Ott M; Delsol G; Orfao A; Tiemann M; Herbst H; Langerak AW; Spaargaren M; Moreau E; Groenen PJ; Sambade C; Foroni L; Carter GI; Hummel M; Bastard C; Davi F; Delfau-Larue MH; Kneba M; van Dongen JJ; Beldjord K; Molina TJ
Leukemia; 2007 Feb; 21(2):215-21. PubMed ID: 17170730
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.
Kidman J; Principe N; Watson M; Lassmann T; Holt RA; Nowak AK; Lesterhuis WJ; Lake RA; Chee J
Front Immunol; 2020; 11():587014. PubMed ID: 33163002
[TBL] [Abstract][Full Text] [Related]
10. Resolving T-cell receptor clonality in two and genotype in four multiplex polymerase chain reactions.
Dictor M; Warenholt J; Isinger A
Haematologica; 2005 Nov; 90(11):1524-32. PubMed ID: 16266900
[TBL] [Abstract][Full Text] [Related]
11. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
Wu Y; Fu J; Wang H; Yu XZ
Front Immunol; 2021; 12():778996. PubMed ID: 34950143
[TBL] [Abstract][Full Text] [Related]
12. Immune Repertoire Sequencing Using Molecular Identifiers Enables Accurate Clonality Discovery and Clone Size Quantification.
Ma KY; He C; Wendel BS; Williams CM; Xiao J; Yang H; Jiang N
Front Immunol; 2018; 9():33. PubMed ID: 29467754
[TBL] [Abstract][Full Text] [Related]
13. Normal and pathological V(D)J recombination: contribution to the understanding of human lymphoid malignancies.
Dadi S; Le Noir S; Asnafi V; Beldjord K; Macintyre EA
Adv Exp Med Biol; 2009; 650():180-94. PubMed ID: 19731811
[TBL] [Abstract][Full Text] [Related]
14. An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood.
Uddin I; Joshi K; Oakes T; Heather JM; Swanton C; ; Chain B
Methods Mol Biol; 2019; 1884():15-42. PubMed ID: 30465193
[TBL] [Abstract][Full Text] [Related]
15. Clonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patients.
Albertini MR; Macklin MD; Zuleger CL; Newton MA; Judice SA; Albertini RJ
Environ Mol Mutagen; 2008 Dec; 49(9):676-87. PubMed ID: 18712786
[TBL] [Abstract][Full Text] [Related]
16. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones.
Maciejewski JP; O'Keefe C; Gondek L; Tiu R
Folia Histochem Cytobiol; 2007; 45(1):5-14. PubMed ID: 17378239
[TBL] [Abstract][Full Text] [Related]
17. TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer.
Looney TJ; Topacio-Hall D; Lowman G; Conroy J; Morrison C; Oh D; Fong L; Zhang L
Front Immunol; 2019; 10():2985. PubMed ID: 31993050
[TBL] [Abstract][Full Text] [Related]
18. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.
Plasilova M; Risitano A; Maciejewski JP
Hematology; 2003 Jun; 8(3):173-81. PubMed ID: 12745651
[TBL] [Abstract][Full Text] [Related]
19. The clinical applications of immunosequencing.
Bardwell B; Bay J; Colburn Z
Curr Res Transl Med; 2024 Jan; 72(3):103439. PubMed ID: 38447267
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.
Zhang H; Liu L; Zhang J; Chen J; Ye J; Shukla S; Qiao J; Zhan X; Chen H; Wu CJ; Fu YX; Li B
Clin Cancer Res; 2020 Mar; 26(6):1359-1371. PubMed ID: 31831563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
